1AI
Click for more information
0.00% 1.0¢ algorae pharmaceuticals limited

Hello gang,came across this interview between 'The Wall Street...

  1. SleepingWolf
    179 Posts.
    lightbulb Created with Sketch. 3
    clock Created with Sketch.
    16/07/08
    16:29
    Post #: 3999688
    Hello gang,

    came across this interview between 'The Wall Street Transcript' and Dr Paul Tan from a couple of weeks ago (in case you havent seen it).

    See link below

    http://www.lct.com.au/news/TheWallStreetTranscriptofLCTInterview.pdf

    Nothing new and exciting but they still look to be headed in the right direction.


    Cheers


    SW
    LCT Price at posting: 0.0¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
1.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $16.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $2K 200K

Buyers (Bids)

No. Vol. Price($)
5 4435009 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 4596 1
View Market Depth
Last trade - 10.03am 03/07/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.